American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 1 , Pages 55-61, January 2011

Antioxidant micronutrient impact on hearing disorders: concept, rationale, and evidence☆☆

  • Gerald M. Haase, MD

      Affiliations

    • University of Colorado, School of Medicine, Premier Micronutrient Corporation, Clinical Programs Center, Denver, Colorado, USA
    • Corresponding Author InformationCorresponding author. 5655 South Grape Court, Greenwood Village, CO 80121, USA. Tel.: +1 720 201 5057; fax: +1 303 770 2790.
    • The first three authors are shareholders in Premier Micronutrient Corporation.
  • ,
  • Kedar N. Prasad, PhD

      Affiliations

    • Premier Micronutrient Corporation, Antioxidant Research Institute, Novato, California, USA
    • The first three authors are shareholders in Premier Micronutrient Corporation.
  • ,
  • William C. Cole, PhD

      Affiliations

    • Premier Micronutrient Corporation, Antioxidant Research Institute, Novato, California, USA
    • The first three authors are shareholders in Premier Micronutrient Corporation.
  • ,
  • Jewell M. Baggett-Strehlau, AuD

      Affiliations

    • Audiology & Hearing Health, PC., Nashville, Tennessee, USA
  • ,
  • Suzanne E. Wyatt, CNM

      Affiliations

    • The EAR Foundation, Nashville, Tennessee, USA

Received 22 June 2009 published online 09 November 2009.

Abstract 

Purpose

Although auditory disorders are complex conditions, device-related modalities dominate current treatment. However, dysfunction from the central cortex to the inner ear apparatus is increasingly thought to be related to biochemical pathway abnormalities and to free radical–induced oxidative damage and chronic inflammation. Therefore, considering appropriate biologic therapy as an adjunct to standard care against these damaging factors may provide rational expansion of treatment options for otolaryngologists and audiologists.

Methods

This review outlines the biologic concepts related to some auditory and vestibular conditions and details the current rationale for utilizing antioxidants for a spectrum of hearing disorders. The strategy is based on the authors' collective experience in antioxidant science and supported with published research, pilot animal data and preliminary clinical observations.

Results

A comprehensive micronutrient approach was developed to exploit these pathways, and demonstrated safety and efficacy against oxidative damage and inflammation and clinically relevant neuroprotection. Cooperative research with Department of Defense institutions used prospective, randomized designs to show (1) reduction in oxidative damage measured in plasma and urine over six months, (2) protection against oxidative damage during 12 weeks of intense military training, (3) protection against inflammation after total body blast exposure (rodents), (4) strong neuroprotection against chemically-induced Parkinson's disease (rodents), (5) nerve VIII function improvement after concussive head injury in military personnel, and (6) tinnitus improvement in majority of patients after 90-day evaluation.

Conclusion

This systematic review of biologic strategies against hearing disorders combined with new animal and human observations may provide a rational basis for expanding current practice paradigms.

 

 This paper was presented, in part, at the Annual Meeting of the Academy of Doctors of Audiology meeting, November, 2008, Las Vegas, NV.

☆☆ The pilot studies detailed in the last section of the manuscript were partially supported by Department of Defense appropriations through Navy RDT&E:

Line 24, PE 0603729N, Warfighter Protection Advanced Technology

Line 183, PE 0603635M, Marine Corps Ground Combat/Supporting Arms Systems

Line 130, PE 0604771N, Medical Development

PII: S0196-0709(09)00207-5

doi:10.1016/j.amjoto.2009.09.002

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 1 , Pages 55-61, January 2011